Safety and efficacy of HLBLS-200 (BleeFix) as a novel hemostatic agent in hepatic surgery: a multicenter, randomized, active-controlled clinical trial
{{output}}
Purpose: This study aimed to evaluate the safety and efficacy of HLBLS-200 (BleeFix, HLB Cell Co., Ltd.) in patients requiring hemostasis for exudative bleeding following primary hemostasis during hepatic resection. ... ...
